Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics
RRDCD development involves multiple factors. Glucocorticoids mitigate retinal damage by suppressing inflammation, regulating oxidative stress, and promoting cell repair. APOD and VTN correlate with BCVA, while APOD, SAA4, and ubiquitin-conjugating enzyme E2 show promise as diagnostic biomarkers for RRDCD.
Authors
- Pingping Li
- Jing Yuan (ORCID: https://orcid.org/0000-0002-0061-8199)
- Mengyao Han (ORCID: https://orcid.org/0000-0001-6304-0446)
- Ning Ma (ORCID: https://orcid.org/0000-0002-1775-2992)
- Yanzi Li (ORCID: https://orcid.org/0000-0001-8966-0256)
- Jianhua Wu (ORCID: https://orcid.org/0000-0002-7817-8461)
- Rui Zhang (ORCID: https://orcid.org/0000-0001-5256-675X)
- Lu Li (ORCID: https://orcid.org/0000-0002-2809-7866)
- Fangyu Chen (ORCID: https://orcid.org/0000-0001-5924-2352)
Institutions
- Wuhan University (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- PROTEOMICS - CLINICAL APPLICATIONS
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1002/prca.70008
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00